The management of lobular carcinoma in situ (LCIS). Is LCIS the same as ductal carcinoma in situ (DCIS)?

European Journal of Cancer

Volumn 42, Issue 14, 2006, Pages 2205-2211

  Lakhani, Sunil R ^a   Audretsch, Werner ^b   Cleton Jensen, Anne Marie ^c   Cutuli, Bruno ^d   Ellis, Ian ^e   Eusebi, Vincenzo ^f   Greco, Marco ^g   Houslton, Richard S ^h   Kuhl, Christiane K ⁱ   Kurtz, John ^d   Palacios, Jose ^j   Peterse, Hans ^k   Rochard, France ^l   Rutgers, E ^k   on behalf of EUSOMA, ^d  

^a UNIVERSITY OF QUEENSLAND   (Australia)

^b Interdisciplinary Breast Center IBC   (Germany)

^c LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^d Polyclinique de Courlancy ^*

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^f UNIVERSITY OF BOLOGNA   (Italy)

^g NATIONAL CANCER INSTITUTE   (Italy)

^h INSTITUTE OF CANCER RESEARCH   (United Kingdom)

ⁱ UNIVERSITY OF BONN   (Germany)

^j Centro Nacional de Investigaciones Oncológicas   (Spain)

^k NETHERLANDS CANCER INSTITUTE   (Netherlands)

^l INSTITUT GUSTAVE ROUSSY   (France)

more..

Author keywords

[No Author keywords available]

Indexed keywords

DNA; UVOMORULIN;

ARTICLE; ASPIRATION BIOPSY; BREAST BIOPSY; BREAST CARCINOGENESIS; BREAST CARCINOMA; CANCER ADJUVANT THERAPY; CANCER GROWTH; CANCER INVASION; CANCER PATIENT; CANCER RADIOTHERAPY; CANCER RISK; CARCINOMA IN SITU; COMPARATIVE GENOMIC HYBRIDIZATION; DIAGNOSTIC APPROACH ROUTE; DIAGNOSTIC IMAGING; FOLLOW UP; GENE DELETION; GENE IDENTIFICATION; GENE LOCUS; HETEROZYGOSITY LOSS; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; MAMMOGRAPHY; MOLECULAR GENETICS; NEEDLE BIOPSY; OUTCOME ASSESSMENT; PLEOMORPHIC ADENOMA; POSTMENOPAUSE; PREOPERATIVE EVALUATION; PRIORITY JOURNAL; PROMOTER REGION; RISK ASSESSMENT; TISSUE SECTION;

ADULT; BREAST NEOPLASMS; CARCINOMA IN SITU; CARCINOMA, DUCTAL, BREAST; CARCINOMA, LOBULAR; FEMALE; HUMANS; MIDDLE AGED;

EID: 33748254919     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2006.03.019     Document Type: Article

References (66)

1. Ewing J. Neoplastic diseases. 1st ed. (1919), WB Saunders, Philadelphia
2. Foote F.W., and Stewart F.W. Lobular carcinoma in situ. Am J Pathol (1941) 491-495
3. Haagensen C.D., Lane N., Lattes R., et al. Lobular neoplasia (so-called lobular carcinoma in situ) of the breast. Cancer 42 2 (1978) 737-769
4. In: Tavassoli F.A., and Devilee P. (Eds). Tumours of the breast and female genital organs. 3rd ed. (2003), IARC Press, Lyon
5. In: Tavassoli F.A., and Devillee P. (Eds). World Health Organisation Classification of tumours: pathology and genetics of tumours of the breast and female genital organs (2003), IARC Press, Lyon
6. Schnitt S.J., and Morrow M. Lobular carcinoma in situ: current concepts and controversies. Semin Diagn Pathol 16 3 (1999) 209-223
7. Page D.L., Dupont W.D., Rogers L.W., et al. Atypical hyperplastic lesions of the female breast. A long-term follow- up study. Cancer 55 11 (1985) 2698-2708
8. Simpson P.T., Gale T., Fulford L.G., et al. The diagnosis and management of pre-invasive breast disease: pathology of atypical lobular hyperplasia and lobular carcinoma in situ. Breast Cancer Res 5 5 (2003) 258-262
9. Eusebi V., Betts C., Haagensen Jr. D.E., et al. Apocrine differentiation in lobular carcinoma of the breast: a morphologic, immunologic, and ultrastructural study. Hum Pathol 15 2 (1984) 134-140
10. Merino M.J., and Livolsi V.A. Signet ring carcinoma of the female breast: a clinicopathologic analysis of 24 cases. Cancer 48 8 (1981) 1830-1837
11. Middleton L.P., Palacios D.M., Bryant B.R., et al. Pleomorphic lobular carcinoma: morphology, immunohistochemistry, and molecular analysis. Am J Surg Pathol 24 12 (2000) 1650-1656
12. Tot T. The diffuse type of invasive lobular carcinoma of the breast: morphology and prognosis. Virchows Arch 443 6 (2003) 718-724
13. Bentz J.S., Yassa N., and Clayton F. Pleomorphic lobular carcinoma of the breast: clinicopathologic features of 12 cases. Mod Pathol 11 9 (1998) 814-822
14. Abner A.L., Connolly J.L., Recht A., et al. The relation between the presence and extent of lobular carcinoma in situ and the risk of local recurrence for patients with infiltrating carcinoma of the breast treated with conservative surgery and radiation therapy. Cancer 88 5 (2000) 1072-1077
15. Sasson A.R., Fowble B., Hanlon A.L., et al. Lobular carcinoma in situ increases the risk of local recurrence in selected patients with stages I and II breast carcinoma treated with conservative surgery and radiation. Cancer 91 10 (2001) 1862-1869
16. Pinder S.E., and Ellis I.O. The diagnosis and management of pre-invasive breast disease: ductal carcinoma in situ (DCIS) and atypical ductal hyperplasia (ADH)-current definitions and classification. Breast Cancer Res 5 5 (2003) 254-257
17. Mohsin S.K., O'Connell P., Allred D.C., et al. Biomarker profile and genetic abnormalities in lobular carcinoma in situ. Breast Cancer Res Treat 90 3 (2005) 249-256
18. Rudas M., Neumayer R., Gnant M.F., et al. p53 protein expression, cell proliferation and steroid hormone receptors in ductal and lobular in situ carcinomas of the breast [see comments]. Eur J Cancer 33 1 (1997) 39-44
19. Gamallo C., Palacios J., Suarez A., et al. Correlation of E-cadherin expression with differentiation grade and histological type in breast carcinoma. Am J Pathol 142 4 (1993) 987-993
20. Rasbridge S.A., Gillett C.E., Sampson S.A., et al. Epithelial (E-) and placental (P-) cadherin cell adhesion molecule expression in breast carcinoma. J Pathol 169 2 (1993) 245-250
21. Somerville J.E., Clarke L.A., and Biggart J.D. c-erbB-2 overexpression and histological type of in situ and invasive breast carcinoma. J Clin Pathol 45 1 (1992) 16-20
22. Sneige N., Wang J., Baker B.A., et al. Clinical, histopathologic, and biologic features of pleomorphic lobular (ductal-lobular) carcinoma in situ of the breast: a report of 24 cases. Mod Pathol 15 10 (2002) 1044-1050
23. Bratthauer G.L., Moinfar F., Stamatakos M.D., et al. Combined E-cadherin and high molecular weight cytokeratin immunoprofile differentiates lobular, ductal, and hybrid mammary intraepithelial neoplasias. Hum Pathol 33 6 (2002) 620-627
24. Li C.I., Daling J.R., and Malone K.E. Age-specific incidence rates of in situ breast carcinomas by histologic type, 1980 to 2001. Cancer Epidemiol Biomarkers Prev 14 4 (2005) 1008-1011
25. Sapino A., Frigerio A., Peterse J.L., et al. Mammographically detected in situ lobular carcinomas of the breast. Virchows Arch 436 5 (2000) 421-430
26. Georgian-Smith D., and Lawton T.J. Calcifications of lobular carcinoma in situ of the breast: radiologic-pathologic correlation. AJR Am J Roentgenol 176 5 (2001) 1255-1259
27. Page D.L., Kidd Jr. T.E., Dupont W.D., et al. Lobular neoplasia of the breast: higher risk for subsequent invasive cancer predicted by more extensive disease. Hum Pathol 22 12 (1991) 1232-1239
28. Urban J. Bilaterality of cancer of the breast: Biopsy of the opposite breast. Cancer 20 (1967) 1867-1870
29. Rosen P.P., Kosloff C., Lieberman P.H., et al. Lobular carcinoma in situ of the breast. Detailed analysis of 99 patients with average follow-up of 24 years. Am J Surg Pathol 2 3 (1978) 225-251
30. Rosen P.P., Senie R., Schottenfeld D., et al. Noninvasive breastcarcinoma: frequency of unsuspected invasion and implications for treatment. Ann Surg 189 3 (1979) 377-382
31. Andersen J.A. Lobular carcinoma in situ. A long-term follow-up in52 cases. Acta Pathol Microbiol Scand[A] 82 (1974) 519-533
32. Ottesen G.L., Graversen H.P., Blichert-Toft M., et al. Lobular carcinoma in situ of the female breast. Short-term results of a prospective nationwide study. The Danish Breast Cancer Cooperative Group. Am J Surg Pathol 17 1 (1993) 14-21
33. Dupont W.D., and Page D.L. Risk factors for breast cancer in women with proliferative breast disease. N Engl J Med 312 3 (1985) 146-151 Issn: 0028-4793
34. Andersen J.A. Lobular carcinoma in situ of the breast. An approach to rational treatment. Cancer 39 (1977) 2597-2602
35. Haagensen C.D., Lane N., and Bodian C. Coexisting lobular neoplasia and carcinoma of the breast. Cancer 51 8 (1983) 1468-1482
36. Page D.L., Schuyler P.A., Dupont W.D., et al. A typical lobular hyperplasia as a unilateral predictor of breast cancer risk: a retrospective cohort study. Lancet 361 9352 (2003) 125-129
37. Marshall L.M., Hunter D.J., Connolly J.L., et al. Risk of breast cancer associated with atypical hyperplasia of lobular and ductal types. Cancer Epidemiol Biomarkers Prev 6 5 (1997) 297-301
38. Wheeler J.E., Enterline H.T., Roseman J.M., et al. Lobular carcinoma in situ of the breast. Long-term followup. Cancer 34 3 (1974) 554-563
39. Maluf H.M., Swanson P.E., and Koerner F.C. Solid low-grade in situ carcinoma of the breast: role of associated lesions and E-cadherin in differential diagnosis. Am J Surg Pathol 25 2 (2001) 237-244
40. Rosen P.P. Coexistent lobular carcinoma in situ and intraductal carcinoma in a single lobular-duct unit. Am J Surg Pathol 4 3 (1980) 241-246
41. Vos C.B., Cleton-Jansen A.M., Berx G., et al. E-cadherin inactivation in lobular carcinoma in situ of the breast: an early event in tumorigenesis. Br J Cancer 76 9 (1997) 1131-1133
42. Lakhani S.R., Jacquemier J., Sloane J.P., et al. Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90 15 (1998) 1138-1145
43. Lakhani S.R., Gusterson B.A., Jacquemier J., et al. The pathology of familial breast cancer: histological features of cancers in families not attributable to mutations in BRCA1 or BRCA2. Clin Cancer Res 6 3 (2000) 782-789
44. Rahman N., Stone J.G., Coleman G., et al. Lobular carcinoma in situ of the breast is not caused by constitutional mutations in the E-cadherin gene. Br J Cancer 82 3 (2000) 568-570
45. Lu Y.J., Osin P., Lakhani S.R., et al. Comparative genomic hybridization analysis of lobular carcinoma in situ and atypical lobular hyperplasia and potential roles for gains and losses of genetic material in breast neoplasia. Cancer Res 58 20 (1998) 4721-4727
46. Buerger H., Otterbach F., Simon R., et al. Different genetic pathways in the evolution of invasive breast cancer are associated with distinct morphological subtypes. J Pathol 189 4 (1999) 521-526
47. Nishizaki T., Chew K., Chu L., et al. Genetic alterations in lobular breast cancer by comparative genomic hybridization. Int J Cancer 74 5 (1997) 513-517
48. Lakhani S., Collins N., Sloane J., et al. Loss of Heterozygosity in lobular carcinoma in situ of the breast. J Clin Pathol: Mol Pathol 48 (1995) M74-M78
49. Nayar R., Zhuang Z., Merino M.J., et al. Loss of heterozygosity on chromosome 11q13 in lobular lesions of the breast using tissue microdissection and polymerase chain reaction. Hum Pathol 28 3 (1997) 277-282
50. Jiang W.G., and Mansel R.E. E-cadherin complex and its abnormalities in human breast cancer. Surg Oncol 9 4 (2000) 151-171
51. Berx G., Cleton-Jansen A.M., Nollet F., et al. E-cadherin is a tumour/invasion suppressor gene mutated in human lobular breast cancers. Embo J 14 24 (1995) 6107-6115
52. Berx G., Cleton-Jansen A.M., Strumane K., et al. E-cadherin is inactivated in a majority of invasive human lobular breast cancers by truncation mutations throughout its extracellular domain. Oncogene 13 9 (1996) 1919-1925
53. Roylance R., Droufakou S., Gorman P., et al. The role of E-cadherin in low-grade ductal breast tumourigenesis. J Pathol 200 1 (2003) 53-58
54. Jacobs T.W., Pliss N., Kouria G., et al. Carcinomas in situ of the breast with indeterminate features: role of E-cadherin staining in categorization. Am J Surg Pathol 25 2 (2001) 229-236
55. Keller G., Vogelsang H., Becker I., et al. Diffuse type gastric and lobular breast carcinoma in a familial gastric cancer patient with an E-cadherin germline mutation. Am J Pathol 155 2 (1999) 337-342
56. Leach M.O., Boggis C.R., Dixon A.K., et al. Screening with magnetic resonance imaging and mammography of a UK population at high familial risk of breast cancer: a prospective multicentre cohort study (MARIBS). Lancet 365 9473 (2005) 1769-1778
57. Elsheikh T.M., and Silverman J.F. Follow-up surgical excision is indicated when breast core needle biopsies show atypical lobular hyperplasia or lobular carcinoma in situ: a correlative study of 33 patients with review of the literature. Am J Surg Pathol 29 4 (2005) 534-543
58. Foster M.C., Helvie M.A., Gregory N.E., et al. Lobular carcinoma in situ or atypical lobular hyperplasia at core-needle biopsy: is excisional biopsy necessary?. Radiology 231 3 (2004) 813-819
59. Dershaw D.D. Does LCIS or ALH without other high-risk lesions diagnosed on core biopsy require surgical excision?. Breast J 9 1 (2003) 1-3
60. Harvey J.M., Sterrett G.F., and Frost F.A. Atypical ductal hyperplasia and atypia of uncertain significance in core biopsies from mammographically detected lesions: correlation with excision diagnosis. Pathology 34 5 (2002) 410-416
61. Shin S.J., and Rosen P.P. Excisional biopsy should be performed if lobular carcinoma in situ is seen on needle core biopsy. Arch Pathol Lab Med 126 6 (2002) 697-701
62. Berg W.A., Mrose H.E., and Ioffe O.B. Atypical lobular hyperplasia or lobular carcinoma in situ at core-needle breast biopsy. Radiology 218 2 (2001) 503-509
63. O'Driscoll D., Britton P., Bobrow L., et al. Lobular carcinoma in situ on core biopsy-what is the clinical significance?. Clin Radiol 56 3 (2001) 216-220
64. Cutuli B., de Lafontan B., Quetin P., et al. Breast-conserving surgery and radiotherapy: a possible treatment for lobular carcinoma in situ?. Eur J Cancer 41 3 (2005) 380-385
65. Fisher B., Land S., Mamounas E., et al. Prevention of invasive breast cancer in women with ductal carcinoma in situ: an update of the national surgical adjuvant breast and bowel project experience. Semin Oncol 28 4 (2001) 400-418
66. Fisher E.R., Costantino J., Fisher B., et al. Pathologic findings from the National Surgical Adjuvant Breast Project (NSABP) Protocol B-17. Five-year observations concerning lobular carcinoma in situ. Cancer 78 7 (1996) 1403-1416